Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study.
Infection control and hospital epidemiology • Vol. 44, Issue 7 • 2023
In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.
International journal of antimicrobial agents • Vol. 35, Issue 6 • 2010
XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms.
The Journal of antimicrobial chemotherapy • Vol. 65, Issue 1 • 2010
XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity.
The Journal of antimicrobial chemotherapy • Vol. 64, Issue 4 • 2009
